Opioid supplementation to propofol anaesthesia for outpatient abortion: a comparison between alfentanil, fentanyl and placebo.
One hundred and sixty-four patients scheduled for elective termination of pregnancy under general anaesthesia were randomly assigned to receive one of three different supplements to propofol and oxygen in nitrous oxide anaesthesia: 0.1 mg fentanyl, 0.5 mg alfentanil or placebo. Postoperative pain and nausea, as well as complications during anaesthesia were studied. There were no differences in complications or complaints by surgeons during anaesthesia, and no patient in any group reacted unsatisfactorily to surgery. The patients in the placebo group consumed significantly more propofol during the procedure (P less than 0.001). No differences were seen in time until hospital discharge between the three groups. Complaints about postoperative pain were significantly less frequent among patients receiving fentanyl (P less than 0.01). The number of patients requesting postoperative analgetics, however, did not differ. There was no difference in the frequency of nausea or vomiting, but postoperative pain was found significantly to increase complaints of nausea (P less than 0.01) and also time until hospital discharge (P less than 0.01). In conclusion, opioid supplementation lowered the amount of propofol needed for anaesthesia. Alfentanil 0.5 mg did not improve the postoperative course. Fentanyl 0.1 mg decreased the frequency of postoperative pain without increasing the time to hospital discharge.
Jakobsson
J
J
Department of Anaesthesia, Karolinska Institute, Danderyds Hospital, Sweden.
Davidson
S
S
Andreen
M
M
Westgreen
M
M
D000028:Abortion, Induced; D000293:Adolescent; D000328:Adult; D015760:Alfentanil / Q000627:therapeutic use*; D000762:Anesthesia Recovery Period; D000771:Anesthesia, Intravenous; D000773:Anesthesia, Obstetrical; D005260:Female; D005283:Fentanyl / Q000627:therapeutic use*; D006801:Humans; D007902:Length of Stay; D009325:Nausea / Q000517:prevention & control; D010149:Postoperative Pain / Q000517:prevention & control; D011247:Pregnancy; D015742:Propofol / Q000008:administration & dosage; D014839:Vomiting / Q000517:prevention & control
D015760:Alfentanil; D005283:Fentanyl; D015742:Propofol